Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Silhouette of an infant in a syringe against a dark background

Jun 10, 2026

US sanctions hurting Cubas healthcare, economy; Havana seeks stronger biotech partnership with India: Cuban scientist

US sanctions have profoundly affected Cuba's healthcare and economy, prompting the nation to seek stronger biotech collaborations with India, according to Cuban neuroscientist Mitchell Valdes-Sosa.Valdes-Sosa emphasized that the long-standing US sanctions have created significant hurdles for Cuba's healthcare system, including challenges in importing essential supplies and sustaining public health services. He noted that the sanctions have directly contributed to worsening health indicators, suc
A stained breast tissue sample under a microscope in a clinical lab setting.

Jun 10, 2026

Uncertainty-aware AI and lensfree holography enable reliable automated HER2 assessment for breast cancer diagnostics

Researchers at UCLA have introduced an innovative approach to breast cancer diagnostics by combining uncertainty-aware AI with lensfree holographic imaging for automated HER2 assessment.This new computational pathology platform leverages a compact lensfree imaging system that captures diffraction patterns from stained breast tissue samples. By employing deep learning techniques with Bayesian uncertainty quantification, the system not only predicts HER2 scores but also assesses the confidence of
A minimalist illustration of a robotic arm and surgical tool in flat design.

Jun 10, 2026

Medical robotics and AI advice from a J&J DePuy Synthes leader

In a recent discussion, Janardhan (JR) Ramachandran, the President of Global Digital and Robotics Surgery at DePuy Synthes, emphasized the importance of addressing real-world surgical challenges rather than simply promoting artificial intelligence (AI) for its own sake. He advocates for a collaborative approach with surgeons to identify meaningful innovations that enhance patient care.Ramachandran outlined three significant applications of AI in medical devices: decision support, workflow automa
A minimalist representation of a microchip and circuit board in a tech-themed design.

Jun 10, 2026

Vice PM Bae holds talks in Belgium with EU on AI, science and technology cooperation

Vice Prime Minister Bae Kyeong-hoon engaged in discussions in Brussels with EU officials to enhance collaboration in AI and scientific research.During his state visit to Belgium, Vice Prime Minister Bae Kyeong-hoon, who also oversees the Ministry of Science and ICT, met with Ekaterina Zaharieva, the EU Commissioner for Startups, Research, and Innovation. Their talks primarily focused on expanding cooperative efforts in artificial intelligence and advanced technology sectors, building on South Ko
A minimalist heart rate monitor with a data stream

Jun 10, 2026

The pulse of progress: AI, real-world data, and the ethics of continuous monitoring in healthcare

Artificial intelligence is revolutionizing the healthcare landscape by enhancing access to health data and empowering patients. The integration of AI with wearable technologies and continuous monitoring offers unprecedented opportunities for individuals to engage with their health information directly, breaking down traditional barriers.However, as this transformation unfolds, the importance of data quality and ethical considerations cannot be overstated. AI systems depend on the integrity of th
An ECG monitor next to a patient's wrist in a hospital room at dusk.

Jun 10, 2026

Medicalgorithmics S.A. stock (PLMDCLG00015): cardiac diagnostics specialist in focus after recent co

Medicalgorithmics S.A., a Polish company specializing in cardiac diagnostics, has recently garnered significant investor interest following updates on its corporate strategies and financial performance. The firm is positioned within the expanding digital cardiology sector, focusing on advanced analytics and remote patient monitoring.The latest financial disclosures reveal that Medicalgorithmics is refining its business model to enhance service revenues and profitability in a rapidly evolving mar
A minimalist illustration of a pill bottle and price tag in a dark palette.

Jun 10, 2026

Pharma Giants Clash with Germany Over Price Caps

Pfizer has signaled potential changes to its investment strategy in Germany, amid rising tensions between pharmaceutical companies and government price control measures.In a recent communication, CEO Albert Bourla informed Chancellor Friedrich Merz that the company is reassessing its planned investments in Germany due to proposed government initiatives aimed at capping drug prices. This move underscores concerns within the pharmaceutical sector about the stability and predictability of investmen
A test tube filled with colorful liquid in a laboratory setting.

Jun 10, 2026

Build AI-Ready Pharma R&D to Accelerate Drug Development, Upcoming Webinar Hosted by Xtalks

A webinar hosted by Xtalks will delve into how AI and unified data platforms can enhance drug development in the pharmaceutical sector. The session aims to provide actionable insights for building an AI-ready infrastructure that fosters innovation while ensuring compliance.As the pharmaceutical industry faces increasing pressure to innovate rapidly and manage complex data landscapes, this webinar will highlight strategies used by leading organizations to integrate AI into their research and deve
A minimalist representation of DNA and data integration

Jun 10, 2026

MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery

MindWalk Holdings Corp. has introduced ReefIQ™, a new biological context layer designed to enhance AI-driven drug discovery and biologics development.This innovative platform aims to bridge the gap in fragmented drug-discovery data, which often exists in disparate formats and systems. By integrating various biological representations—such as sequences, structures, and assay outputs—ReefIQ provides a cohesive, governed context that can be utilized by AI workflows. This integration is critical as
A bottle of RNAi therapeutic medicine on a pharmacy shelf

Jun 10, 2026

GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region

GENESIS Pharma has broadened its strategic partnership with Alnylam Pharmaceuticals, extending its reach into the Nordic region, which includes Denmark, Finland, Norway, and Sweden. This expansion allows GENESIS to commercialize Alnylam’s RNAi therapeutics focused on serious cardiomyopathy conditions and rare genetic diseases.The collaboration, which began in 2019 in Southeast Europe, now encompasses a total of seventeen markets, including countries like Greece, Bulgaria, and Romania. This strat
Minimalist representation of biotech growth

Jun 10, 2026

Why Is the NYSE Composite Spotlighting Biotech, Cannabis and AI Themes?

The NYSE Composite is currently spotlighting key sectors such as biotechnology, cannabis, and artificial intelligence, reflecting significant market dynamics.Biotechnology companies are nearing critical clinical milestones that are capturing investor interest, particularly within speculative market segments. As these firms, like Ardelyx and Windtree Therapeutics, release updates on research and regulatory progress, they become focal points for market participants eager to track advancements in h
A minimalist illustration of a pill symbolizing drug discovery in a dark color scheme.

Jun 10, 2026

AI drug discovery leaders warn U.S. health funding cuts risk falling behind global rivals

Recent cuts in U.S. health funding have raised alarms among leaders in AI drug discovery, who argue that this could hinder the nation's competitive edge in the rapidly evolving biotech landscape.At the Fortune Brainstorm Tech conference, industry experts, including Geoffrey von Maltzahn of Lila Sciences and NVIDIA's Kimberly Powell, highlighted the critical timing of these funding decisions. They emphasized that reducing investment now, while global competitors increase their efforts, could lead